Grant Langdon
Impact in
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology
- HIV/AIDS drug development and treatment
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
Papers in
-
- HIV/AIDS drug development and treatment 8
- Tuberculosis Research and Epidemiology 6
-
- Antibiotics Pharmacokinetics and Efficacy 7
- Co-authors
- Justin Wilkins (6 shared papers)Helen McIlleron (6 shared papers)Peter J. Smith (5 shared papers)Ulrika S. H. Simonsson (5 shared papers)Goonaseelan Pillai (4 shared papers)Mats O. Karlsson (2 shared papers)Peter Kießling (3 shared papers)Stephen Jolles (3 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (4 papers)British Journal of Clinical Pharmacology (4 papers)European Journal of Clinical Pharmacology (4 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- United KingdomUnited StatesSouth Africa
In The Last Decade
Grant Langdon
26 papers receiving 725 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 293
- Pharmacology 89
- Hematology 90
- Pharmacology 136
- Epidemiology 167
Countries citing papers authored by Grant Langdon
This map shows the geographic impact of Grant Langdon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grant Langdon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grant Langdon more than expected).
Fields of papers citing papers by Grant Langdon
This network shows the impact of papers produced by Grant Langdon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grant Langdon. The network helps show where Grant Langdon may publish in the future.
Co-authors
The 25 scholars most cited alongside Grant Langdon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 152 | |
| 2 | 2008 | 122 | |
| 3 | 2020 | 83 | |
| 4 | 2011 | 78 | |
| 5 | 2006 | 60 | |
| 6 | 2020 | 38 | |
| 7 | 2020 | 33 | |
| 8 | 2007 | 30 | |
| 9 | Consecutive-dose pharmacokinetics of rifapentine in patients diagnosed with pulmonary tuberculosis. | 2004 | 21 |
| 10 | 2021 | 21 | |
| 11 | 2005 | 13 | |
| 12 | 2011 | 11 | |
| 13 | 2009 | 11 | |
| 14 | 2012 | 10 | |
| 15 | 2010 | 7 | |
| 16 | 2011 | 7 | |
| 17 | 2006 | 7 | |
| 18 | 2011 | 7 | |
| 19 | 2013 | 4 | |
| 20 | 2005 | 4 |
About Grant Langdon
Grant Langdon is a scholar working on Infectious Diseases, Pharmacology, Epidemiology, Oncology and Molecular Biology, having authored 28 papers that have together received 736 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Tuberculosis Research and Epidemiology (6 papers), Pharmacological Effects and Toxicity Studies (3 papers), HIV Research and Treatment (3 papers), Hepatitis C virus research (3 papers), Malaria Research and Control (3 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Infectious Diseases (293 citations), Pharmacology (89 citations), Hematology (90 citations), Pharmacology (136 citations) and Epidemiology (167 citations). Grant Langdon has collaborated with scholars based in United Kingdom, United States and South Africa. Frequent co-authors include Justin Wilkins, Helen McIlleron, Peter J. Smith, Ulrika S. H. Simonsson, Goonaseelan Pillai, Mats O. Karlsson, Peter Kießling, Stephen Jolles, Radojka M. Savić and Shikiko Watanabe. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, JAIDS Journal of Acquired Immune Deficiency Syndromes and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.